George Tidmarsh is a millionaire co-founder of a biotech firm, serial entrepreneur, neonatologist and adjunct professor at ...

Sickle cell disease treatment progress has improved over the years, but recent federal cuts threaten the health of those who suffer from the blood ailment.

Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...